MS & griepprik

Interferon-beta (Avonex®, Betaferon®, Rebif®, Plegridy®) en glatirameer-acetaat (Copaxone®, Mylan®)

Teriflunomide (Aubagio®) en dimethylfumaraat (Tecfidera®)

Fingolimod (Gilenya®), ozanimod (Zeposia®), ponesimod (Ponvory®), siponimod (Mayzent®)

Natalizumab (Tysabri®)

Ocrelizumab (Ocrevus®), ofatumumab (Kesimpta®)

Cladribine (Mavenclad®)

Alemtuzumab (Lemtrada®)

Methylprednisolon stootkuur

Stamcelbehandeling

Code NEU-332
Laatste revisie: 5 november 2024 - 12:55